Diagnosis and classification of Kawasaki disease.

[1]  M. Cheung,et al.  Update on Kawasaki disease: Epidemiology, aetiology and pathogenesis , 2013, Journal of paediatrics and child health.

[2]  Tomio Kobayashi,et al.  Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease. , 2013, The Journal of pediatrics.

[3]  M. Cheung,et al.  An update on Kawasaki disease II: Clinical features, diagnosis, treatment and outcomes , 2013, Journal of paediatrics and child health.

[4]  M. Gunshin,et al.  Coronary artery aneurysms after adult-onset Kawasaki disease. , 2013, Circulation.

[5]  Y. Fukuda,et al.  Etanercept Suppresses Arteritis in a Murine Model of Kawasaki Disease: A Comparative Study Involving Different Biological Agents , 2013, International journal of vascular medicine.

[6]  Lucila Ohno-Machado,et al.  Differential Expression of miR-145 in Children with Kawasaki Disease , 2013, PloS one.

[7]  G. Chrousos,et al.  Epidemiology and Risk Factors for Coronary Artery Abnormalities in Children With Complete and Incomplete Kawasaki Disease During a 10-Year Period , 2013, Pediatric Cardiology.

[8]  Y. Hong,et al.  Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease? , 2013, Korean circulation journal.

[9]  Jane C Burns,et al.  Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. , 2012, The Journal of pediatrics.

[10]  T. Kuijpers,et al.  A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation , 2012, Annals of the rheumatic diseases.

[11]  K. Kotani,et al.  Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey , 2012, Journal of epidemiology.

[12]  M. Guedes,et al.  Kawasaki disease and sensorineural hearing loss: an (un)expected complication , 2012, European Journal of Pediatrics.

[13]  Tien Yin Wong,et al.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease , 2011, Nature Genetics.

[14]  Xavier Rodó,et al.  Association of Kawasaki disease with tropospheric wind patterns , 2011, Scientific reports.

[15]  G. Vaiopoulos,et al.  Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management. , 2011, Autoimmunity reviews.

[16]  Fuu-Jen Tsai,et al.  Identification of Novel Susceptibility Loci for Kawasaki Disease in a Han Chinese Population by a Genome-Wide Association Study , 2011, PloS one.

[17]  Tomio Kobayashi,et al.  External Validation of a Risk Score to Predict Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease , 2011, The Pediatric infectious disease journal.

[18]  A. Rowley.  Kawasaki disease: novel insights into etiology and genetic susceptibility. , 2011, Annual review of medicine.

[19]  Yeon-Su Lee,et al.  A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease , 2011, Human Genetics.

[20]  R. Pratesi,et al.  Sensorineural Hearing Loss: An Underdiagnosed Complication of Kawasaki Disease , 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[21]  Yusuke Nakamura,et al.  Common variants in CASP3 confer susceptibility to Kawasaki disease. , 2010, Human molecular genetics.

[22]  R. Holman,et al.  Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007 , 2010, The Pediatric infectious disease journal.

[23]  A. Martinot,et al.  Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. , 2009, The Journal of pediatrics.

[24]  B. McCrindle,et al.  Kawasaki Disease at the Extremes of the Age Spectrum , 2009, Pediatrics.

[25]  K. Narahara,et al.  Kawasaki Disease in an 8-Day-Old Neonate , 2009, Pediatric Cardiology.

[26]  Anbupalam Thalamuthu,et al.  A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease , 2009, PLoS genetics.

[27]  J. Newburger,et al.  Resistance to intravenous immunoglobulin in children with Kawasaki disease. , 2008, The Journal of pediatrics.

[28]  J. Orenstein,et al.  Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight , 2008, Nature Reviews Microbiology.

[29]  C. Broussolle,et al.  Kawasaki-like syndromes in HIV-infected adults. , 2007, The Journal of infection.

[30]  M. Nishijima,et al.  Release of the Lipopolysaccharide Deacylase PagL from Latency Compensates for a Lack of Lipopolysaccharide Aminoarabinose Modification-Dependent Resistance to the Antimicrobial Peptide Polymyxin B in Salmonella enterica , 2007, Journal of bacteriology.

[31]  R. Holman,et al.  Kawasaki Syndrome in Denmark , 2007, The Pediatric infectious disease journal.

[32]  T. Matsuishi,et al.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2006, The Journal of pediatrics.

[33]  Tomio Kobayashi,et al.  Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.

[34]  Marco Antonio Yamazaki Nakashimada,et al.  Reactivación de la cicatriz de la vacuna BCG en la enfermedad de Kawasaki: caso clínico y revisión de la bibliografía , 2006 .

[35]  P Woo,et al.  EULAR/PReS endorsed consensus criteria* for the classification of childhood vasculitides , 2005, Annals of the rheumatic diseases.

[36]  J. Newburger,et al.  Familial occurrence of Kawasaki syndrome in North America. , 2005, Archives of pediatrics & adolescent medicine.

[37]  D. Cayan,et al.  Seasonality and Temporal Clustering of Kawasaki Syndrome , 2005, Epidemiology.

[38]  B. Gottlieb,et al.  Infliximab as a novel therapy for refractory Kawasaki disease. , 2004, The Journal of rheumatology.

[39]  T. Stanley,et al.  Classical Kawasaki disease in a neonate , 2002, Archives of disease in childhood. Fetal and neonatal edition.

[40]  H. Yanagawa,et al.  Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan , 2001, Acta paediatrica.

[41]  D. Sherry,et al.  Initial intravenous gammaglobulin treatment failure in Kawasaki disease. , 2000, Pediatrics.

[42]  B. C. Lee,et al.  Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[43]  K. Durongpisitkul,et al.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. , 1995, Pediatrics.

[44]  K. Harada.  Intravenous γ‐Globulin Treatment in Kawasaki Disease , 1991 .

[45]  H. Yanagawa,et al.  Kawasaki disease in families. , 1989, Pediatrics.

[46]  J. Newburger,et al.  Kawasaki syndrome and the eye. , 1989, The Pediatric infectious disease journal.

[47]  B. Reid,et al.  Hydrops of the gallbladder associated with Kawasaki syndrome. , 1987, Journal of pediatric surgery.

[48]  M. Nagashima,et al.  High-dose gammaglobulin therapy for Kawasaki disease. , 1987, The Journal of pediatrics.

[49]  F. Hazama,et al.  NEURAL INVOLVEMENT IN KAWASAKI DISEASE , 1980, Acta pathologica japonica.